Small Molecules

22 May 2007 Nektar Therapeutics Announces Phase 2a Clinical Results Regarding the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative Hospital-Acquired Pneumonia Presented at the Annual American Thoracic Society International Conference
22 May 2007 Cougar Biotechnology Announces Presentation of Positive CB7630 Clinical Data at AUA Annual Meeting
22 May 2007 Pooled Studies Showed Desvenlafaxine Succinate Significantly Improved Painful Symptoms and Anxious Symptoms Associated with Major Depressive Disorder in Adults, Compared With Placebo
22 May 2007 Additional Satraplatin Efficacy Data From Phase 3 SPARC Trial Presented at Annual Meeting of American Urological Association
22 May 2007 Amlodipine and Olmesartan Study Results Released;
19 May 2007 FDA Approves Lovenox (Enoxaparin Sodium Injection) for the Most Severe Type of Heart Attack
19 May 2007 Basilea Announces the Submission to U.S. Authorities of a New Drug Application for Ceftobiprole, a Novel anti-MRSA Broad-spectrum Cephalosporin
18 May 2007 FDA Approves AstraZeneca’s Once-Daily SEROQUEL XR(TM) Extended-Release Tablets For The Treatment Of Schizophrenia
17 May 2007 Trophos Starts Phase II Clinical Trial of TRO19622 in Painful Diabetic Neuropathy
17 May 2007 BioLineRx Initiates a Clinical Receptor-Occupancy Study of BL-1020, First in Class GABA-Enhanced Antipsychotic for the Treatment of Schizophrenia
17 May 2007 Pivotal phase IIIa trials for Organon's novel oral contraceptive, NOMAC/E2, complete recruitment
17 May 2007 InterMune Completes Patient Enrollment in Phase 3 'Capacity' Program Evaluating Pirfenidone in Patients With IPF
17 May 2007 Obecure Initiates Phase II Study to Examine Effect of OBE101 on Plasma Lipids in Patients Treated With Simvastatin
17 May 2007 CollaGenex Pharmaceuticals and QuatRx Pharmaceuticals Announce Agreement for the Development and Commercialization of Becocalcidiol
17 May 2007 Can-Fite to Commence Phase II Clinical Trials to Investigate the Efficacy of CF101 in the Treatment of Psoriasis
17 May 2007 Danube Pharmaceuticals Initiates a Multi-Center Phase II Clinical Trial of DNB-001 in Patients with Ocular Hypertension
17 May 2007 MethylGene Selects Histone Deacetylase Antifungal Clinical Candidate
16 May 2007 Positive Statistical Analysis from Synthetic Blood's Oxycyte Traumatic Brain Injury Trial Indicates Achievement of Primary Endpoint
16 May 2007 SIGA Passes First Hurdle with Lassa Fever Antiviral ST-193
15 May 2007 Wyeth and Progenics Pharmaceuticals Announce Submission of Marketing Application in Europe for the Subcutaneous Formulation of Methylnaltrexone
15 May 2007 Luitpold Pharmaceuticals, Inc., Announces NDA Submission for Injectafer (Ferric Carboxymaltose Injection), a Next Generation Intravenous Iron Product
15 May 2007 Momenta Pharmaceuticals Initiates Phase I Clinical Study for M118 Subcutaneous Formulation
15 May 2007 Critical Therapeutics' Sales Force Gains Access to a Second Product as FDA Approves Co-Promotion Partner's New Treatment for COPD
15 May 2007 Skyepharma PLC and Sciele Pharma Announce Successful Completion of New Sular(R) Formulation Clinical Trial Programme
15 May 2007 Avicena Initiates Phase I Clinical Trial in Amyotrophic Lateral Sclerosis (ALS)

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2019 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up